Express

Leading Pharmaceutical Biotechnology Soars Nearly 240% Intraday, Announces Plan to Acquire Conflux

Summary: Leading Pharmaceutical Biotechnology, a Hong Kong-listed company, surged significantly in early trading today, rising nearly 240% at one point before narrowing gains. The stock price reached 0.7 Hong Kong dollars before retreating to around 0.34 Hong Kong dollars. The company had previously announced plans to acquire all shares of Conflux to expand into the blockchain ...

Leading Pharmaceutical Biotechnology, a Hong Kong-listed company, surged significantly in early trading today, rising nearly 240% at one point before narrowing gains. The stock price reached 0.7 Hong Kong dollars before retreating to around 0.34 Hong Kong dollars. The company had previously announced plans to acquire all shares of Conflux to expand into the blockchain sector, with two founding members of Conflux serving as its executive directors.

Last Update:

Tags:
Link: Leading Pharmaceutical Biotechnology Soars Nearly 240% Intraday, Announces Plan to Acquire Conflux [Copy]

Last: 1RT Acquisition Corp. Plans to Raise $150 Million Through IPO to Expand Digital Assets, Fintech Business

Next: Analysis: Strengthening Cooperation between Hong Kong and Shanghai to Form a Positive Development Pattern for Onshore Digital RMB and Offshore RMB Stablecoins

Global Financial Giants Enter Stablecoin Arena in Pivotal Shift 13 days ago

CRYPTO'S NEW PLAY: 24/7 STOCK TRADING 14 days ago

Gold’s $2.1 Trillion Plunge: Where Is The Smart Money Flowing Next? 21 days ago

GAEA Chat Singapore Concludes Successfully - A Recap of the Industry Thought Feast Duri... October 5, 2025

U.S. SEC Clears Path for Institutional Crypto Custody, Recognizing State Trust Companie... October 1, 2025